Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AS4.1 |
Mouse kidney tumor cell line | ATCC CRL-2193 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. H. Vogel, Dissertation, 2021, Universität Greifswald | Link | |
AS4.1 |
Mouse kidney tumor cell line | ATCC CRL-2193 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Wanka et al., J. Cell. Mol. Med., 2017, 21 (7): 1394-1410 | Link | |
ASBhTERT |
PCNT defective hTERT immortalized cell line | unknown | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Stiff et al., Hum. Mol. Genet., Apr 2016; 25: 1574 - 1587 | Link | ||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
ATC1 |
Murine adrenocortical tumor cell line | Murine | other | cell line | siRNA | RNA-Interference | Metafectene | publication | A.-M. Lefrancois-Martinez et al., J. Biol. Chem., Sep 2011; 286: 32976 - 32985 | Link | |||
ATC1 |
Murine adrenocortical tumor cell line | Murine | other | cell line | siRNA | RNA-Interference | Metafectene | publication | A.-M. Lefrancois-Martinez et al., J. Biol. Chem., 2011, 286 (38) : 32976–32985, DOI 10.1074/jbc.M111.218016 | Link | |||
beta-TC6 |
Mouse pancreatic tumor (insulinoma) derived ß cell line | ATCC CRL-11506 | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Tsuruta et al., Hormone and Metabolic Research 2017, DOI: 10.1055/s-0043-121467 | ||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. A. Zhang et al., Bio Protoc., 2018, 8 (1): doi:10.21769/BioProtoc.2680 | Link | ||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Crummy et al., J. Biol. Chem., 2019, doi/10.1074/jbc.RA119.007504 | Link | ||
BT-20 |
Human breast cancer cell line | ATCC HTB-19 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
BT549 |
Human mammary gland cells | ATCC HTB-122 | Human | breast | unknown | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
BV-2 |
Mouse microglial cell line | Mouse | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M.-J. Choi et al., Biochemical Pharmacology, 2017, 144: 120-131 | |||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Hatem-Vaquero et al., J. Endocrinol., May 2017, doi: 10.1530/JOE-16-0662 | ||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Qiu et al., Cell Death and Differentiation, 2016, 23: 1658-1669, doi:10.1038/cdd.2016.56 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Alcantara, PhD Thesis, 2012, University of Sussex | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Taler, Mol Endocrinology 2003;17:1580 | ||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Youn et al., Scientific Reportss, 2018, 8: 12323, DOI:10.1038/s41598-018-30513-7 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Youn et al., Scientific Reports, 2018, 8:12323, DOI:10.1038/s41598-018-30513-7 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P. Sosa et al., Aging and Disease, 2018, 9(5): 769-784, doi.org/10.14336/AD.2017.1214 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
C3H/10T1/2 |
Mouse embryonic mesenchymal cell line | ATCC CCL-226 | Mouse | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. M. Musri et al., J. Biol. Chem., Sep 2010; 285: 30034 - 30041 | Link | |
C3H/10T1/2 |
Mouse embryonic mesenchymal cell line | ATCC CCL-226 | Mouse | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | T. Wang et al., Phytotherapy Research., 2019, 33: 1074–1083, DOI: 10.1002/ptr.6301 | Link | |
C4-2 |
Human prostate carcinoma cell line (derivat of LNCaP) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. S. R. Sastry et al., J. Biol. Chem., Jul 2006; 281: 20891 - 20901 | Link | ||
C6 |
Rat glial cell line | ATCC CCL-107 | Rat | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Serrano et al., Hindawi Mediators of Inflammation, 2017, Art.- ID 1626204, doi.org/10.1155/2017/1626204 |